OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
miR‐363‐3p induces EMT via the Wnt/β‐catenin pathway in glioma cells by targeting CELF2
Bo Fan, Bolun Su, Guoqiang Song, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 22, pp. 10418-10429
Open Access | Times Cited: 13
Bo Fan, Bolun Su, Guoqiang Song, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 22, pp. 10418-10429
Open Access | Times Cited: 13
Showing 13 citing articles:
Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs
Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115187-115187
Open Access | Times Cited: 9
Aryan Rezaee, Pooya M. Tehrany, Farimah Jafari Tirabadi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115187-115187
Open Access | Times Cited: 9
miRNA-363-3p Hinders Proliferation, Migration, Invasion and Autophagy of Thyroid Cancer Cells by Controlling SYT1 Transcription to affect NF-κB
Jizong Zhang, Guanghui Ren, Tao Huang, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 1, pp. 153-162
Closed Access | Times Cited: 7
Jizong Zhang, Guanghui Ren, Tao Huang, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 1, pp. 153-162
Closed Access | Times Cited: 7
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175781-175781
Closed Access | Times Cited: 7
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175781-175781
Closed Access | Times Cited: 7
Role of microRNA-363 during tumor progression and invasion
Arya Nasimi Shad, Iman Akhlaghipour, Hawraa Ibrahim Alshakarchi, et al.
Journal of Physiology and Biochemistry (2024) Vol. 80, Iss. 3, pp. 481-499
Closed Access | Times Cited: 2
Arya Nasimi Shad, Iman Akhlaghipour, Hawraa Ibrahim Alshakarchi, et al.
Journal of Physiology and Biochemistry (2024) Vol. 80, Iss. 3, pp. 481-499
Closed Access | Times Cited: 2
MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine
Huali Fan, Xiaofang Xie, Xi Kuang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1799-1825
Closed Access | Times Cited: 10
Huali Fan, Xiaofang Xie, Xi Kuang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1799-1825
Closed Access | Times Cited: 10
Role of CELF2 in ferroptosis: Potential targets for cancer therapy (Review)
Jiahao Li, Lei Xian, Zifeng Zhu, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 4
Open Access | Times Cited: 4
Jiahao Li, Lei Xian, Zifeng Zhu, et al.
International Journal of Molecular Medicine (2023) Vol. 52, Iss. 4
Open Access | Times Cited: 4
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
Laurent Turchi, Nathalie Sakakini, Gaëlle Saviane, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5038-5038
Open Access | Times Cited: 4
Laurent Turchi, Nathalie Sakakini, Gaëlle Saviane, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5038-5038
Open Access | Times Cited: 4
The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort
Friedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
Friedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1
Novel cancer-fighting role of ticagrelor inhibits GTSE1-induced EMT by regulating PI3K/Akt/NF-κB signaling pathway in malignant glioma
Enzhou Lu, Boxian Zhao, Chao Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30833-e30833
Open Access | Times Cited: 1
Enzhou Lu, Boxian Zhao, Chao Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30833-e30833
Open Access | Times Cited: 1
Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis
Zhijian Zhang, Yanping Mo, Lixuan Wu, et al.
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 923-934
Closed Access | Times Cited: 4
Zhijian Zhang, Yanping Mo, Lixuan Wu, et al.
Anti-Cancer Drugs (2022) Vol. 33, Iss. 9, pp. 923-934
Closed Access | Times Cited: 4
MicroRNA-429 overexpression overcomes imatinib resistance of glioma cells by negatively regulating lysophosphatidic acid receptor 1
Junzhe Xia, Zhiping Peng, Meina Zhang, et al.
Neurological Research (2024) Vol. 46, Iss. 12, pp. 1149-1159
Closed Access
Junzhe Xia, Zhiping Peng, Meina Zhang, et al.
Neurological Research (2024) Vol. 46, Iss. 12, pp. 1149-1159
Closed Access
EMX1 functions as a tumor inhibitor in spinal cord glioma through transcriptional suppression of WASF2 and inactivation of the Wnt/β‐catenin axis
Ziyin Han, Zufang Mou, Yulong Jing, et al.
Brain and Behavior (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 1
Ziyin Han, Zufang Mou, Yulong Jing, et al.
Brain and Behavior (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 1
